Pregnancy and isotretinoin (Accutane): poor adherence to pregnancy prevention program is concerning

Interview with Dr. Brandace Winquist, research consultant with the Saskatchewan Health Quality Council, a maternal-perinatal health researcher, and a collaborator with the Canadian Network for Observational Drug Effect Studies. In a research article she co-authored, Dr. Winquist and her colleagues found that the isotretinoin/accutane pregnancy prevention program in Canada was relatively ineffective over a 15-year period in which nearly 60 000 women in 4 provinces received prescriptions for the drug. Risks of maternal isotretinoin therapy to the developing fetus are well recognized.Full research article: https://www.cmaj.ca/lookup/doi/10.1503/cmaj.151243To request a transcript of this podcast, contact cmajgroup@cmaj.caSubscribe to CMAJ Podcasts on Apple Podcasts or your favourite podcast app. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.

Comments or questions? Text us.

Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.

You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole

X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca

The CMAJ Podcast is produced by PodCraft Productions